Table 3.
Neonatal Risk Factors Associated with Acute Kidney Injury (AKI)
| Risk Factor | All Infants (N = 143), n (%) | Infants with AKI (n = 62), n (%) | Infants without AKI (n = 81), n (%) | p value* |
|---|---|---|---|---|
| NSAIDs (any) | 38 (26.6) | 30 (48.4) | 8 (9.9) | <0.001† |
| INDO prophylactic | 8 (5.6) | 6 (9.7) | 2 (2.5) | 0.077 |
| INDO treatment | 39 (27.3) | 32 (51.6) | 7 (8.6) | <0.001† |
| Inotropes | 26 (18.2) | 23 (37.1) | 3 (3.7) | <0.001† |
| Gentamicin | 132 (92.3) | 59 (95.2) | 73 (90.1) | 0.263 |
| Vancomycin | 12 (8.4) | 3 (4.8) | 9 (11.1) | 0.232 |
| Severe IVH | 6 (4.2) | 5 (8.1) | 1 (1.2) | 0.086 |
| Patent ductus arteriosus | 37 (25.9) | 30 (48.4) | 7 (8.6) | <0.001† |
INDO, indomethacin; IVH, intraventricular hemorrhage
* To test for differences between groups we used χ2 tests for categorical variables (Fisher's exact test for cells <5).
† Values are statistically significant.